Paolo Aridon

Medicine · Health Sciences

35h-index4.3kcitations132works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(22), Parkinson's Disease Mechanisms and Treatments(16), Acute Ischemic Stroke Management(12), Intracerebral and Subarachnoid Hemorrhage Research(10), Atrial Fibrillation Management and Outcomes(6)

Publications129 total

Clinical and genetic findings of three patients with chorea-acanthocytosis
Neurological Sciences·2026
Risk of Cognitive Decline in Women with Parkinson’s Disease Is Reduced by Early Age at Menarche
Neurology International·2025Open Access
Shed Syndecans (1–3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson’s Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Performance of a Modified Version of the Charlson Comorbidity Index in Predicting Multiple Sclerosis Disability Accrual
Neuroepidemiology·2025· 1 cited
A population based study to analyse amyotrophic lateral sclerosis as a multi-step process
Scientific Reports·2025· 1 citedOpen Access
The Impact of In‐Hospital Disease Modifying Treatments on Mental and Physical Burden in Caregiver of Patients With <scp>MS</scp>
Annals of Clinical and Translational Neurology·2025Open Access
Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous Thrombosis
JAMA Neurology·2024· 11 citedOpen Access
Efficacy and Safety of Rescue Treatment with Plasma Exchange in Patients with Acute Inflammatory Neurological Disorders: A Single Center Experience
Neurology International·2024· 1 citedOpen Access
Statin Therapy in Ischemic Stroke Patients with Atrial Fibrillation: Efficacy and Safety Outcomes
2024Open Access
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study
Clinical and Applied Thrombosis/Hemostasis·2024· 3 citedOpen Access
COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
Frontiers in Neurology·2023· 10 citedOpen Access
A scoring tool to predict mortality and dependency after cerebral venous thrombosis
European Journal of Neurology·2023· 13 citedOpen Access
Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against <scp>SARS‐CoV</scp>‐2
Annals of Clinical and Translational Neurology·2023· 1 citedOpen Access
A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
Frontiers in Neurology·2022· 73 citedOpen Access
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study
Stroke·2022· 70 citedOpen Access
Vitamin D and Parkinson’s Disease
Nutrients·2022· 85 citedOpen Access
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
Neurology International·2021· 22 citedOpen Access
Autonomic symptoms in motor subtypes of Parkinson's disease
Journal of the Neurological Sciences·2021
Case series: Multiple sclerosis clinical onset and relapse after SARS-CoV-2 Infection
Journal of the Neurological Sciences·2021Open Access
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
Stroke·2021· 15 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Paolo Ragonese(27), Giovanni Savettieri(25), Marco D’Amelio(21), Giuseppe Salemi(19), Giorgio Casari(12), Maurizio De Fusco(10), Valeria Terruso(10), Valentina Arnao(9), Giorgia Famoso(6), Andrea Ballabio(5), Norma Di Benedetto(5), Francesca Morgante(4), Valentina Saia(4), Maria Antonietta Mazzola(4), Barbara Palmeri(4), Jukka Putaala(4), Renzo Guerrini(3), Antonio Epifanio(3), I Lupo(3), Sergio Mastrilli(3)